Medical News Today -
12 Dec 2013 12:00
The Leuven-based VIB researchers have revealed a mechanism that explains why the anti-tumor activity of specific immune cells called macrophages is suppressed during tumor growth. They have also demonstrated that blocking the protein Nrp1 can restore this anti-tumor immune response. This is a first. Nrp1 may provide an important hub for the development of new therapies against cancer. Max Mazzone: "For many years the biological processes which lead to the coordinated navigation of blood vessels ...
Share this Article
Comment on this Article
Please to comment